MedPath
HSA Approval

TERIZIN TABLETS 10 mg

SIN11214P

TERIZIN TABLETS 10 mg

TERIZIN TABLETS 10 mg

November 4, 1999

PHARMAFORTE SINGAPORE PTE LTD

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMAFORTE SINGAPORE PTE LTD
Licence HolderPHARMAFORTE SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

R06AE07

cetirizine

Manufacturer Information

PHARMAFORTE SINGAPORE PTE LTD

SEOUL PHARM CO LTD

Active Ingredients

CETIRIZINE 2HCl

10 mg

Cetirizine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

TERIZIN TABLETS 10 mg - HSA Approval | MedPath